Katie Steenackers

422 total citations
5 papers, 63 citations indexed

About

Katie Steenackers is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Katie Steenackers has authored 5 papers receiving a total of 63 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 2 papers in Infectious Diseases and 1 paper in Surgery. Recurrent topics in Katie Steenackers's work include Respiratory viral infections research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). Katie Steenackers is often cited by papers focused on Respiratory viral infections research (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). Katie Steenackers collaborates with scholars based in Belgium, United States and Italy. Katie Steenackers's co-authors include Pierre Van Damme, Ananda S Bandyopadhyay, Christopher Gast, Kanchanamala Withanage, John F. Modlin, John Konz, Isabel Leroux‐Roels, Novilia Sjafri Bachtiar, Sue Ann Costa Clemens and Alan Fix and has published in prestigious journals such as The Lancet, Diabetes and Vaccine.

In The Last Decade

Katie Steenackers

3 papers receiving 62 citations

Peers

Katie Steenackers
Likun Lv China
Carmen Pérez‐González Spain
Mónica Gozalo-Margüello Spain
Fengcai Zhu China
Caroline Ciric United States
Maria Júlia Silveira Souto Brazil
Katie Bernard United States
Hazel Morrison United Kingdom
Louise Berry United Kingdom
Hannah C. Howson‐Wells United Kingdom
Likun Lv China
Katie Steenackers
Citations per year, relative to Katie Steenackers Katie Steenackers (= 1×) peers Likun Lv

Countries citing papers authored by Katie Steenackers

Since Specialization
Citations

This map shows the geographic impact of Katie Steenackers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Steenackers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Steenackers more than expected).

Fields of papers citing papers by Katie Steenackers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Steenackers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Steenackers. The network helps show where Katie Steenackers may publish in the future.

Co-authorship network of co-authors of Katie Steenackers

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Steenackers. A scholar is included among the top collaborators of Katie Steenackers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Steenackers. Katie Steenackers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Steenackers, Katie, Nikita Hanning, Liesbeth Bruckers, et al.. (2024). Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial. Vaccine. 42(25). 126117–126117. 1 indexed citations
2.
Feldman, Robert G., Raffaele Antonelli Incalzi, Katie Steenackers, et al.. (2023). 280-LB: Efficacy of a Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults with Preexisting Medical Conditions. Diabetes. 72(Supplement_1). 3 indexed citations
3.
4.
Coster, Ilse De, Isabel Leroux‐Roels, Ananda S Bandyopadhyay, et al.. (2020). Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials. The Lancet. 397(10268). 39–50. 58 indexed citations
5.
Andrews, Charles P., Matthew Davis, Brandon Essink, et al.. (2020). 119. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Well Tolerated. Open Forum Infectious Diseases. 7(Supplement_1). S187–S188. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Likun Lv Breakdown of academic impact, for papers by Carmen Pérez‐González Breakdown of academic impact, for papers by Mónica Gozalo-Margüello Breakdown of academic impact, for papers by Fengcai Zhu Breakdown of academic impact, for papers by Caroline Ciric Breakdown of academic impact, for papers by Maria Júlia Silveira Souto Breakdown of academic impact, for papers by Katie Bernard Breakdown of academic impact, for papers by Hazel Morrison Breakdown of academic impact, for papers by Louise Berry Breakdown of academic impact, for papers by Hannah C. Howson‐Wells
Rankless by CCL
2026